NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Akeso Biomedical, Inc.

Akeso Biomedical, Inc.

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://akesobiomedical.com/

Last Round

Pre Seed

Feb 9, 2021

Total Funding Raised

$6.33M

Company Overview

Akeso Biomedical, Inc. is a food safety company that develops antibiotic-free feed additives to improve the gut health of farm animals and reduce bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

animal feed additivesantibiotic alternativesfood safetyanimal healthpathogen reductionFe3C technologyanimal gut healthagtechiron chelatefoodborne illness preventionzootechnical feed additivepoultry healthswine healthTYPLEX Chelateregulatory dossier services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akeso Biomedical, Inc. Comps

Public and private peers based on sector, stage, and business model.

Akeso Biomedical, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Akeso Biomedical, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 9, 2021
Pre SeedNov 8, 2019
Series AMay 31, 2017
SeedJul 15, 2015
SeedDec 4, 2014
View all Funding Rounds

Key People

Founding team and executive leadership

Simon Williams

Chief Executive Officer

Executive Team

Akeso Biomedical, Inc. Investors

Notable investors and investment history

Akeso Biomedical, Inc. investors
InvestorRounds
VIC Technology Venture DevelopmentSeries A, Pre Seed, Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 10, 2025

    Monthly visitors increased 90% MoM.

  • May 2, 2025

    Monthly visitors grew 302% MoM, reaching 1.5K.

View all signals

Akeso Biomedical, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Akeso Biomedical, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Akeso Biomedical, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range2
Year Founded2014
Last FundingFeb 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.